Search - tctmd.com

Displaying 381 - 400 of 916

Sort: Relevancy | Date

News Conference News AHA 2015

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

L.A. McKeown

November 09, 2015

News Industry News

Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch Stent

November 01, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

News Industry News

AV Medical Technologies Ltd. Receives FDA Clearance for its Chameleon™ Angioplasty Balloon Catheter

October 27, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

DCB治疗膝下病变又传出令人失望的消息

L.A. McKeown

October 26, 2015

News Daily News

Turning Fellows to Flowers: John S. Douglas, Jr., Transforms Trainees at One of the Longest-Running Interventional Fellowship Programs

Yael L. Maxwell

October 20, 2015

News Conference News TCT 2015

TCT Remembers Liliana Grinfeld, MD, PhD

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Mortality Increasing in Elderly PCI Patients

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

Advertisement

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch Stent

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

AV Medical Technologies Ltd. Receives FDA Clearance for its Chameleon™ Angioplasty Balloon Catheter

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

DCB治疗膝下病变又传出令人失望的消息

Turning Fellows to Flowers: John S. Douglas, Jr., Transforms Trainees at One of the Longest-Running Interventional Fellowship Programs

TCT Remembers Liliana Grinfeld, MD, PhD

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Very Late Stent Thrombosis Remains an Important Clinical Target

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Mortality Increasing in Elderly PCI Patients

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content